MyoKardia

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MyoKardia and buy or sell other stocks, options, and ETFs commission-free!

About MYOK

MyoKardia is a clinical-stage biopharmaceutical company that engages in discovering, developing, and commercializing targeted therapies for the treatment of rare cardiovascular diseases. The company's focus is on the treatment of heritable cardiomyopathies and genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. 

CEO
Tassos Gianakakos, MBA
CEOTassos Gianakakos, MBA
Employees
Employees
Headquarters
Brisbane, California
HeadquartersBrisbane, California
Founded
2012
Founded2012
Employees
Employees

MYOK Key Statistics

Market cap
11.99B
Market cap11.99B
Price-Earnings ratio
-39.87
Price-Earnings ratio-39.87
Dividend yield
Dividend yield
Average volume
1.31M
Average volume1.31M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$225.00
52 Week high$225.00
52 Week low
$42.65
52 Week low$42.65
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.